Symbols / SLGL $79.75 +2.00%
SLGL Chart
About
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 222.16M |
| Enterprise Value | 202.40M | Income | -8.99M | Sales | 18.97M |
| Book/sh | 9.34 | Cash/sh | 7.48 | Dividend Yield | — |
| Payout | 0.00% | Employees | 34 | IPO | — |
| P/E | — | Forward P/E | -11.71 | PEG | — |
| P/S | 11.71 | P/B | 8.53 | P/C | — |
| EV/EBITDA | -20.09 | EV/Sales | 10.67 | Quick Ratio | 4.99 |
| Current Ratio | 5.15 | Debt/Eq | 4.16 | LT Debt/Eq | — |
| EPS (ttm) | -3.23 | EPS next Y | -6.81 | EPS Growth | — |
| Revenue Growth | -92.50% | Earnings | 2026-05-01 | ROA | -16.48% |
| ROE | -29.59% | ROIC | — | Gross Margin | -28.71% |
| Oper. Margin | -15.72% | Profit Margin | -47.37% | Shs Outstand | 2.79M |
| Shs Float | 229.02K | Short Float | 0.78% | Short Ratio | 0.31 |
| Short Interest | — | 52W High | 97.97 | 52W Low | 4.02 |
| Beta | 1.22 | Avg Volume | 27.11K | Volume | 17.28K |
| Target Price | $110.00 | Recom | None | Prev Close | $78.18 |
| Price | $79.75 | Change | 2.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$110.00
Mean price target
2. Current target
$79.75
Latest analyst target
3. DCF / Fair value
$110.00
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$79.75
Low
$110.00
High
$110.00
Mean
$110.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-20 | main | HC Wainwright & Co. | Buy → Buy | $110 |
| 2025-12-22 | reit | HC Wainwright & Co. | Buy → Buy | $50 |
| 2025-10-27 | main | HC Wainwright & Co. | Buy → Buy | $50 |
| 2024-08-19 | down | Raymond James | Strong Buy → Outperform | $4 |
| 2024-05-22 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-20 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-11-13 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2023-08-14 | main | HC Wainwright & Co. | Buy → Buy | $12 |
| 2023-08-11 | main | Raymond James | Strong Buy → Strong Buy | $7 |
| 2023-07-24 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2023-07-19 | main | Raymond James | Strong Buy → Strong Buy | $9 |
| 2023-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2023-04-12 | reit | HC Wainwright & Co. | — → Buy | $19 |
| 2023-03-14 | main | Raymond James | — → Strong Buy | $10 |
| 2023-02-01 | reit | HC Wainwright & Co. | — → Buy | $19 |
| 2022-11-14 | main | HC Wainwright & Co. | — → Buy | $19 |
| 2022-11-11 | main | Raymond James | — → Strong Buy | $13 |
| 2022-10-21 | init | Jefferies | — → Hold | $6 |
| 2022-08-29 | main | HC Wainwright & Co. | — → Buy | $22 |
| 2022-05-16 | main | Raymond James | — → Strong Buy | $16 |
- (SLGL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily Sun, 15 Mar 2026 19
- Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update - MarketBeat Fri, 13 Mar 2026 19
- This Under-the-Radar Stock Has Surged 1,300% Over the Past Year - Yahoo Finance hu, 12 Mar 2026 15
- Form 144 shows insider sale examples (SLGL) via Oppenheimer & Co. - Stock Titan hu, 26 Feb 2026 08
- $SLGL stock is up 9% today. Here's what we see in our data. - Quiver Quantitative Mon, 26 Jan 2026 08
- Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st hu, 15 Jan 2026 08
- Sol-Gel Technologies (SLGL) Price Target Increased by 120.00% to 112.20 - Nasdaq ue, 03 Feb 2026 08
- Sol-Gel halts studies for rare disease drug (SLGL:NASDAQ) - Seeking Alpha Wed, 17 Dec 2025 08
- Sol-Gel Technologies (SLGL) to Release Earnings on Wednesday - MarketBeat Wed, 04 Mar 2026 08
- Itzik Yosef to sell 1,170 SLGL ordinary shares (NASDAQ: SLGL) - Stock Titan ue, 24 Feb 2026 08
- Revenues Not Telling The Story For Sol-Gel Technologies Ltd. (NASDAQ:SLGL) After Shares Rise 30% - simplywall.st hu, 11 Dec 2025 08
- (SLGL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily Wed, 04 Mar 2026 17
- We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth - Yahoo Finance Mon, 29 Dec 2025 08
- Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Decreases By 23.4% - MarketBeat Mon, 02 Mar 2026 08
- Sol-Gel Technologies (NASDAQ:SLGL) pops 10% this week, taking one-year gains to 278% - simplywall.st Fri, 19 Sep 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 291 | 18333 | — | Purchase at price 63.00 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-13 00:00:00 | I |
| 1 | 100 | 5800 | — | Purchase at price 58.00 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-02 00:00:00 | I |
| 2 | 100 | 5800 | — | Purchase at price 58.00 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-02 00:00:00 | I |
| 3 | 100 | 5705 | — | Purchase at price 57.05 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-27 00:00:00 | I |
| 4 | 3324 | 187356 | — | Purchase at price 55.98 - 56.57 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-23 00:00:00 | I |
| 5 | 2592 | 108858 | — | Purchase at price 41.92 - 42.98 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-05 00:00:00 | I |
| 6 | 66304 | 2782904 | — | Purchase at price 41.85 - 41.99 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-31 00:00:00 | I |
| 7 | 2905 | 120533 | — | Purchase at price 41.15 - 41.68 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-26 00:00:00 | I |
| 8 | 2735 | 110412 | — | Purchase at price 40.37 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-17 00:00:00 | I |
| 9 | 87 | 3480 | — | Purchase at price 40.00 per share. | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-12 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.25 |
| NormalizedEBITDA | -11.78M | -28.96M | -15.68M | 3.84M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -10.58M | -27.24M | -14.92M | 3.22M |
| ReconciledDepreciation | 233.00K | 342.00K | 562.00K | 880.00K |
| EBITDA | -11.78M | -28.96M | -15.68M | 3.84M |
| EBIT | -12.01M | -29.30M | -16.24M | 2.96M |
| NetInterestIncome | 1.43M | 2.07M | 1.32M | 257.00K |
| InterestIncome | 1.43M | 2.07M | 1.32M | 257.00K |
| NormalizedIncome | -10.58M | -27.24M | -14.92M | 3.22M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -10.58M | -27.24M | -14.92M | 3.22M |
| TotalExpenses | 23.55M | 30.86M | 20.13M | 28.31M |
| TotalOperatingIncomeAsReported | -12.01M | -29.30M | -16.24M | 2.96M |
| DilutedAverageShares | 2.79M | 2.71M | 2.31M | 2.36M |
| BasicAverageShares | 2.79M | 2.71M | 2.31M | 2.31M |
| DilutedEPS | -3.80 | -10.10 | -6.50 | 1.40 |
| BasicEPS | -3.80 | -10.10 | -6.50 | 1.40 |
| DilutedNIAvailtoComStockholders | -10.58M | -27.24M | -14.92M | 3.22M |
| NetIncomeCommonStockholders | -10.58M | -27.24M | -14.92M | 3.22M |
| NetIncome | -10.58M | -27.24M | -14.92M | 3.22M |
| NetIncomeIncludingNoncontrollingInterests | -10.58M | -27.24M | -14.92M | 3.22M |
| NetIncomeContinuousOperations | -10.58M | -27.24M | -14.92M | 3.22M |
| TaxProvision | 0.00 | |||
| PretaxIncome | -10.58M | -27.24M | -14.92M | 3.22M |
| NetNonOperatingInterestIncomeExpense | 1.43M | 2.07M | 1.32M | 257.00K |
| InterestIncomeNonOperating | 1.43M | 2.07M | 1.32M | 257.00K |
| OperatingIncome | -12.01M | -29.30M | -16.24M | 2.96M |
| OperatingExpense | 23.55M | 30.86M | 20.13M | 28.31M |
| OtherOperatingExpenses | -55.00K | -524.00K | ||
| ResearchAndDevelopment | 17.80M | 23.54M | 12.68M | 20.38M |
| SellingGeneralAndAdministration | 5.75M | 7.37M | 7.45M | 8.45M |
| GeneralAndAdministrativeExpense | 5.75M | 7.37M | 7.45M | 8.45M |
| OtherGandA | 5.75M | 7.37M | 7.45M | 8.45M |
| TotalRevenue | 11.54M | 1.55M | 3.88M | 31.27M |
| OperatingRevenue | 11.54M | 1.55M | 3.88M | 31.27M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 2.79M | 2.79M | 2.31M | 2.31M |
| ShareIssued | 2.79M | 2.79M | 2.31M | 2.31M |
| TotalDebt | 1.31M | 1.65M | 772.00K | 1.59M |
| TangibleBookValue | 28.85M | 38.64M | 42.21M | 55.59M |
| InvestedCapital | 28.85M | 38.64M | 42.21M | 55.59M |
| WorkingCapital | 26.01M | 36.65M | 39.73M | 45.41M |
| NetTangibleAssets | 28.85M | 38.64M | 42.21M | 55.59M |
| CapitalLeaseObligations | 1.31M | 1.65M | 772.00K | 1.59M |
| CommonStockEquity | 28.85M | 38.64M | 42.21M | 55.59M |
| TotalCapitalization | 28.85M | 38.64M | 42.21M | 55.59M |
| TotalEquityGrossMinorityInterest | 28.85M | 38.64M | 42.21M | 55.59M |
| StockholdersEquity | 28.85M | 38.64M | 42.21M | 55.59M |
| RetainedEarnings | -230.88M | -220.30M | -193.06M | -178.14M |
| AdditionalPaidInCapital | 258.96M | 258.17M | 234.64M | 233.10M |
| CapitalStock | 774.00K | 774.00K | 638.00K | 638.00K |
| CommonStock | 774.00K | 774.00K | 638.00K | 638.00K |
| TotalLiabilitiesNetMinorityInterest | 7.00M | 6.64M | 4.42M | 13.60M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.71M | 2.12M | 1.09M | 1.90M |
| EmployeeBenefits | 833.00K | 915.00K | 1.03M | 1.09M |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 833.00K | 915.00K | 1.03M | 1.09M |
| LongTermDebtAndCapitalLeaseObligation | 878.00K | 1.21M | 54.00K | 810.00K |
| LongTermCapitalLeaseObligation | 878.00K | 1.21M | 54.00K | 810.00K |
| CurrentLiabilities | 5.29M | 4.52M | 3.33M | 11.69M |
| CurrentDebtAndCapitalLeaseObligation | 430.00K | 447.00K | 718.00K | 781.00K |
| CurrentCapitalLeaseObligation | 430.00K | 447.00K | 718.00K | 781.00K |
| PayablesAndAccruedExpenses | 4.86M | 4.08M | 2.61M | 10.91M |
| CurrentAccruedExpenses | 1.06M | 2.05M | 1.26M | 1.69M |
| Payables | 3.79M | 2.02M | 1.35M | 9.23M |
| OtherPayable | 2.53M | 1.87M | 1.10M | 8.46M |
| AccountsPayable | 1.26M | 154.00K | 251.00K | 766.00K |
| TotalAssets | 35.85M | 45.29M | 46.63M | 69.19M |
| TotalNonCurrentAssets | 4.55M | 4.12M | 3.57M | 12.08M |
| OtherNonCurrentAssets | 1.30M | 1.34M | 1.29M | 1.30M |
| DefinedPensionBenefit | 595.00K | 626.00K | 749.00K | 830.00K |
| NonCurrentAccountsReceivable | 1.02M | 7.40M | ||
| NetPPE | 1.63M | 2.15M | 1.54M | 2.55M |
| AccumulatedDepreciation | -6.02M | -5.80M | -5.71M | -5.15M |
| GrossPPE | 7.65M | 7.96M | 7.25M | 7.70M |
| Leases | 1.98M | 1.99M | 1.99M | 1.99M |
| OtherProperties | 4.93M | 5.24M | 4.56M | 5.09M |
| MachineryFurnitureEquipment | 740.00K | 739.00K | 693.00K | 622.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 31.30M | 41.17M | 43.05M | 57.11M |
| OtherCurrentAssets | 3.77M | 2.79M | 1.51M | 800.00K |
| PrepaidAssets | 800.00K | |||
| Receivables | 3.60M | 377.00K | 7.92M | 13.06M |
| OtherReceivables | 7.86M | |||
| AccountsReceivable | 3.60M | 377.00K | 62.00K | 13.06M |
| CashCashEquivalentsAndShortTermInvestments | 23.93M | 38.00M | 33.63M | 43.24M |
| OtherShortTermInvestments | 4.44M | 30.48M | 21.18M | 23.16M |
| CashAndCashEquivalents | 19.49M | 7.51M | 12.45M | 20.09M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -13.89M | -17.86M | -9.65M | -7.83M |
| IssuanceOfCapitalStock | 0.00 | 21.54M | 0.00 | 505.00K |
| CapitalExpenditure | -2.00K | -134.00K | -171.00K | -143.00K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 34.00K | |
| EndCashPosition | 20.66M | 7.86M | 13.60M | 21.23M |
| BeginningCashPosition | 7.86M | 13.60M | 21.23M | 8.27M |
| EffectOfExchangeRateChanges | -1.00K | -73.00K | 133.00K | -55.00K |
| ChangesInCash | 12.80M | -5.66M | -7.77M | 13.02M |
| FinancingCashFlow | 0.00 | 21.81M | 15.00K | 837.00K |
| CashFlowFromContinuingFinancingActivities | 0.00 | 21.81M | 15.00K | 837.00K |
| ProceedsFromStockOptionExercised | 0.00 | 268.00K | 15.00K | 332.00K |
| NetCommonStockIssuance | 0.00 | 21.54M | 0.00 | 505.00K |
| CommonStockIssuance | 0.00 | 21.54M | 0.00 | 505.00K |
| InvestingCashFlow | 26.69M | -9.74M | 1.70M | 19.87M |
| CashFlowFromContinuingInvestingActivities | 26.69M | -9.74M | 1.70M | 19.87M |
| NetOtherInvestingChanges | 10.00K | -5.00K | ||
| NetInvestmentPurchaseAndSale | 26.69M | -9.68M | 1.87M | 20.02M |
| SaleOfInvestment | 26.69M | 14.29M | 11.88M | 26.78M |
| PurchaseOfInvestment | 0.00 | -23.98M | -10.01M | -6.77M |
| NetPPEPurchaseAndSale | 4.00K | -60.00K | -171.00K | -143.00K |
| SaleOfPPE | 6.00K | 74.00K | 0.00 | 0.00 |
| PurchaseOfPPE | -2.00K | -134.00K | -171.00K | -143.00K |
| OperatingCashFlow | -13.89M | -17.73M | -9.48M | -7.69M |
| CashFlowFromContinuingOperatingActivities | -13.89M | -17.73M | -9.48M | -7.69M |
| ChangeInWorkingCapital | -4.40M | 7.67M | 3.54M | -12.42M |
| ChangeInOtherWorkingCapital | -174.00K | -18.00K | ||
| ChangeInPayablesAndAccruedExpense | 780.00K | 1.47M | -8.30M | 5.62M |
| ChangeInPayable | 780.00K | 1.47M | -8.30M | 5.62M |
| ChangeInAccountPayable | 780.00K | 1.47M | -8.30M | 5.62M |
| ChangeInPrepaidAssets | -981.00K | -1.34M | -709.00K | 274.00K |
| ChangeInReceivables | -4.20M | 7.54M | 12.55M | -18.31M |
| ChangesInAccountReceivables | -3.22M | 7.54M | 12.55M | -18.31M |
| OtherNonCashItems | -46.00K | 124.00K | -327.00K | 69.00K |
| StockBasedCompensation | 786.00K | 1.86M | 1.53M | 687.00K |
| UnrealizedGainLossOnInvestmentSecurities | 175.00K | -436.00K | 119.00K | -125.00K |
| DepreciationAmortizationDepletion | 233.00K | 342.00K | 562.00K | 880.00K |
| DepreciationAndAmortization | 233.00K | 342.00K | 562.00K | 880.00K |
| Depreciation | 233.00K | 342.00K | 562.00K | 880.00K |
| OperatingGainsLosses | -55.00K | -49.00K | 20.00K | -3.00K |
| PensionAndEmployeeBenefitExpense | -51.00K | 6.00K | 20.00K | -32.00K |
| GainLossOnSaleOfPPE | -4.00K | -55.00K | 0.00 | 29.00K |
| NetIncomeFromContinuingOperations | -10.58M | -27.24M | -14.92M | 3.22M |
Public Trades for SLGL
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|